Soliton and GTO joined forces in September 2020 to help launch the revolutionary RESONIC Rapid Acoustic Pulse™ (RAP) device and establish Soliton as a leader in the aesthetics industry. Today, we are beyond proud to announce the work we have done for RESONIC.
Rebecca Mahadeva, Global Chief Financial Officer, discusses her career in finance and her strategic role at GTO on the CFO THOUGHT LEADER podcast.
See Amanda Powers-Han, CMO, featured in PharmaVOICE’s 2020 Woman of the Week Anthology.
VITAS Healthcare has selected GTO to support their strategic shifts and enhanced ROI from marketing initiatives.
AI, elevated algorithms, and social platforms can help connect the often unseen dots and create a new future for rare disease patients.
